JP2010527346A5 - - Google Patents

Download PDF

Info

Publication number
JP2010527346A5
JP2010527346A5 JP2010507981A JP2010507981A JP2010527346A5 JP 2010527346 A5 JP2010527346 A5 JP 2010527346A5 JP 2010507981 A JP2010507981 A JP 2010507981A JP 2010507981 A JP2010507981 A JP 2010507981A JP 2010527346 A5 JP2010527346 A5 JP 2010527346A5
Authority
JP
Japan
Prior art keywords
methyl
phenylpyrrolidin
quinolin
compound
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010507981A
Other languages
English (en)
Japanese (ja)
Other versions
JP5474768B2 (ja
JP2010527346A (ja
Filing date
Publication date
Priority claimed from GB0709489A external-priority patent/GB0709489D0/en
Priority claimed from GB0807591A external-priority patent/GB0807591D0/en
Application filed filed Critical
Priority claimed from PCT/GB2008/001694 external-priority patent/WO2008142384A1/en
Publication of JP2010527346A publication Critical patent/JP2010527346A/ja
Publication of JP2010527346A5 publication Critical patent/JP2010527346A5/ja
Application granted granted Critical
Publication of JP5474768B2 publication Critical patent/JP5474768B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010507981A 2007-05-17 2008-05-16 臨床的に潜伏性の微生物を殺傷するための4−(ピロリジン−1−イル)キノリン化合物の使用 Expired - Fee Related JP5474768B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0709489.9 2007-05-17
GB0709489A GB0709489D0 (en) 2007-05-17 2007-05-17 New use
GB0807591A GB0807591D0 (en) 2008-04-25 2008-04-25 New use
GB0807591.3 2008-04-25
PCT/GB2008/001694 WO2008142384A1 (en) 2007-05-17 2008-05-16 Use of 4-(pyrrolidin-1-yl)quinoline compounds to kill clinically latent microorganisms

Publications (3)

Publication Number Publication Date
JP2010527346A JP2010527346A (ja) 2010-08-12
JP2010527346A5 true JP2010527346A5 (https=) 2011-06-30
JP5474768B2 JP5474768B2 (ja) 2014-04-16

Family

ID=39672613

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010507981A Expired - Fee Related JP5474768B2 (ja) 2007-05-17 2008-05-16 臨床的に潜伏性の微生物を殺傷するための4−(ピロリジン−1−イル)キノリン化合物の使用

Country Status (20)

Country Link
US (1) US8759348B2 (https=)
EP (1) EP2182950B8 (https=)
JP (1) JP5474768B2 (https=)
KR (1) KR101599384B1 (https=)
CN (1) CN101795688B (https=)
AU (1) AU2008252636B2 (https=)
BR (1) BRPI0811745B1 (https=)
CA (1) CA2684692C (https=)
DK (1) DK2182950T3 (https=)
ES (1) ES2637999T3 (https=)
HR (1) HRP20171553T1 (https=)
HU (1) HUE034298T2 (https=)
IL (1) IL201392A (https=)
MX (1) MX2009012390A (https=)
NZ (1) NZ580625A (https=)
PL (1) PL2182950T3 (https=)
PT (1) PT2182950T (https=)
RU (1) RU2520766C2 (https=)
SI (1) SI2182950T1 (https=)
WO (1) WO2008142384A1 (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010095522A (ja) * 2008-09-19 2010-04-30 Sumitomo Chemical Co Ltd 植物病原菌による植物病害を防除又は予防するための農業用組成物
ES2703253T3 (es) * 2010-03-30 2019-03-07 Helperby Therapeutics Ltd Nueva combinación y uso
CA2798325A1 (en) * 2010-05-13 2011-11-17 Amgen Inc. Heteroaryloxyheterocyclyl compounds as pde10 inhibitors
DK2600869T3 (da) 2010-08-05 2020-11-16 Helperby Therapeutics Ltd Kombination af en pyrroloquinolinforbindelse og et beta-lactam-antimikrobielt middel, mupirocin eller chlorhexidin
GB201013207D0 (en) 2010-08-05 2010-09-22 Helperby Therapeutics Ltd Novel combination
GB201015079D0 (en) 2010-09-10 2010-10-27 Helperby Therapeutics Ltd Novel use
HK1250679A1 (zh) 2015-04-11 2019-01-11 Helperby Therapeutics Limited 口腔用组合物
WO2017027768A1 (en) 2015-08-13 2017-02-16 The Broad Institute, Inc. Compositions and methods for treating tuberculosis
GB201518969D0 (en) 2015-10-27 2015-12-09 Helperby Therapeutics Ltd Triple combination
WO2017120225A1 (en) * 2016-01-04 2017-07-13 The Johns Hopkins University Use of low dose emetine for inhibition of human cytomegalovirus (hcmv)
KR102665309B1 (ko) * 2016-10-27 2024-05-10 주식회사 엘지생활건강 코디세핀을 포함하는 구강질환 예방 또는 치료용 조성물
GB201703898D0 (en) 2017-03-10 2017-04-26 Helperby Therapeautics Ltd Method
RU2664177C1 (ru) * 2017-08-07 2018-08-15 федеральное государственное бюджетное образовательное учреждение высшего образования "Омский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО ОмГМУ Минздрава России) Способ лечения абсцедирующих фурункулов верхней и нижней зон лица
WO2019036657A1 (en) 2017-08-17 2019-02-21 Kyn Therapeutics AHR INHIBITORS AND USES THEREOF
CA3086082A1 (en) * 2017-12-18 2019-06-27 Ansella Therapeutics, Inc. Compositions and methods for preventing and treating conditions
CN110897032B (zh) * 2019-11-19 2025-10-14 华南理工大学 一种发酵饲料蛋白及其制备方法与应用
RU2758056C2 (ru) * 2019-11-21 2021-10-26 федеральное государственное бюджетное образовательное учреждение высшего образования "Ставропольский государственный аграрный университет" Препарат для лечения отитов бактериальной и грибковой этиологии у собак
CN111544599B (zh) * 2020-07-10 2020-12-01 有术肌肤管理(深圳)有限公司 一种用于治疗痤疮的化合物及其用于制备药物或化妆品的用途
KR102461715B1 (ko) * 2020-10-12 2022-11-02 대한민국 항균 및 항진균 활성을 나타내는 신균주 페니실리움 비세티 및 이의 용도
CN114831924A (zh) * 2021-03-17 2022-08-02 武汉恒信源药业有限公司 一种乌洛托品及其化合物的阴道局部给药制剂及用途
CN113528388A (zh) * 2021-07-19 2021-10-22 海南大学 珊瑚共生链霉菌、发酵生产放线菌素d的方法及应用
FI4426434T3 (fi) 2021-11-02 2025-11-24 Flare Therapeutics Inc Pparg:n käänteisagonisteja ja niiden käyttöjä
UY40234A (es) 2022-04-22 2023-11-15 Vertex Pharma Compuestos heteroarilo para el tratamiento del dolor

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW477787B (en) * 1996-08-27 2002-03-01 Pfizer Pyrido six-membered nitrogen-containing cyclic ring derivatives having corticotropin releasing factor antagonist activity and pharmaceutical composition containing same
US7074801B1 (en) 2001-04-26 2006-07-11 Eisai Co., Ltd. Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof
MXPA03010565A (es) * 2001-05-21 2004-03-02 Hoffmann La Roche Derivados de quinolina como ligandos para receptor del neuropeptido y.
US6787558B2 (en) * 2001-09-28 2004-09-07 Hoffmann-La Roche Inc. Quinoline derivatives
AU2002352868A1 (en) * 2001-11-27 2003-06-10 Merck & Co., Inc. 4-aminoquinoline compounds
BR0307441A (pt) * 2002-02-04 2005-01-04 Hoffmann La Roche Compostos, processo para a preparação de um composto, composição farmacêutica, utilização desses compostos, método para o tratamento e profilaxia de enfermidades e método para o tratamento de obesidade
WO2004002960A1 (en) * 2002-06-27 2004-01-08 Schering Aktiengesellschaft Substituted quinoline ccr5 receptor antagonists
KR101189471B1 (ko) * 2002-08-19 2012-10-12 아미트 모르 고유 수용성 및 운동 감각성 부츠
WO2004035569A2 (de) * 2002-10-10 2004-04-29 Morphochem Aktiengesellschaft für kombinatorische Chemie Neue verbindungen mit antibakterieller aktivität
CL2004000409A1 (es) 2003-03-03 2005-01-07 Vertex Pharma Compuestos derivados de 2-(cilo sustituido)-1-(amino u oxi sustituido)-quinazolina, inhibidores de canales ionicos de sodio y calcio dependientes de voltaje; composicion farmaceutica; y uso del compuesto en el tratamiento de dolor agudo, cronico, neu
DE102004041163A1 (de) * 2004-08-25 2006-03-02 Morphochem Aktiengesellschaft für kombinatorische Chemie Neue Verbindungen mit antibakterieller Aktivität
US7880002B2 (en) 2004-12-29 2011-02-01 Millennium Pharmaceuticals, Inc. Substituted piperazinyl-pyrrolidine compounds useful as chemokine receptor antagonists
US20060183763A1 (en) * 2004-12-31 2006-08-17 Pfizer Inc Novel pyrrolidyl derivatives of heteroaromatic compounds
GB0522715D0 (en) * 2005-11-08 2005-12-14 Helperby Therapeutics Ltd New use

Similar Documents

Publication Publication Date Title
JP2010527346A5 (https=)
HRP20171553T1 (hr) Uporaba spojeva 4-(pirolidin-1-il)kinolina za uništavanje klinički latentnih mikroorganizama
JP2009514936A5 (https=)
RU2008122912A (ru) Применение соединений пирролохинолина для уничтожения клинически латентных микроорганизмов
WO2008117079B1 (en) Antimicrobial compounds based upon 4-aminoquinoline
JPWO2020085493A5 (https=)
KR102237887B1 (ko) 항생제를 사용하여 과체중 및 비만 환자에서 감염을 치료하는 방법
CN107980000A (zh) 包含抗菌剂的药物组合物
KR100817425B1 (ko) 피리돈카복실산류를 유효성분으로 하는 항항산균제
RU2012146093A (ru) Новая комбинация и применение
JP2020536966A5 (https=)
CN104884092A (zh) 用于治疗细菌感染的组合物和方法
EP1134219B1 (en) Cycloalkyl-substituted aminomethylpyrrolidine derivatives
AU2011323594B2 (en) Pharmaceutical compositions
JP2013542226A5 (https=)
Fukuda New approaches to overcoming bacterial resistance
EA200970537A1 (ru) Антибактериальные производные хинолина
WO2018162928A1 (en) Method for restoring efficacy of an antibacterial agent
EP3215496A2 (en) Pantothenamide analogues
WO2024186827A2 (en) Novel host-directed therapeutic agent for the treatment of infectious diseases
HK1140146A (en) Use of 4-(pyrrolidin-1-yl)quinoline compounds to kill clinically latent microorganisms
HK1140146B (en) Use of 4-(pyrrolidin-1-yl)quinoline compounds to kill clinically latent microorganisms